Heparanase enzyme is preferentially expressed in obesity-associated breast tumors in clinical/experimental settings [30] and associated with worse prognosis in ER+, but not ER− BC [52]. Here, HPSE is linked to obesity due to melanocortin 4 receptor deficiency.